Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GCTK NASDAQ:ITOC NASDAQ:NXGL NYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGCTKGlucoTrack$0.67-4.3%$0.94$0.58▼$15.90$1.30M0.783.34 million shs340,432 shsITOCItonic$0.31+0.3%$0.33$0.25▼$32.00$5.30M3.233.09 million shs28,960 shsNXGLNexGel$0.54+1.7%$0.71$0.53▼$2.89$4.80M0.74269,935 shs123,240 shsRBOTVicarious Surgical$0.70+1.4%$0.73$0.27▼$13.75$4.99M1.4981,928 shs26,193 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGCTKGlucoTrack-5.39%-17.98%-20.45%-57.06%-92.01%ITOCItonic+3.02%-8.79%+10.36%-24.64%+31,009,900.00%NXGLNexGel-8.10%-11.17%-9.62%-59.31%-80.69%RBOTVicarious Surgical+21.05%+64.29%-11.54%-61.21%-91.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGCTKGlucoTrack$0.67-4.3%$0.94$0.58▼$15.90$1.30M0.783.34 million shs340,432 shsITOCItonic$0.31+0.3%$0.33$0.25▼$32.00$5.30M3.233.09 million shs28,960 shsNXGLNexGel$0.54+1.7%$0.71$0.53▼$2.89$4.80M0.74269,935 shs123,240 shsRBOTVicarious Surgical$0.70+1.4%$0.73$0.27▼$13.75$4.99M1.4981,928 shs26,193 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGCTKGlucoTrack-5.39%-17.98%-20.45%-57.06%-92.01%ITOCItonic+3.02%-8.79%+10.36%-24.64%+31,009,900.00%NXGLNexGel-8.10%-11.17%-9.62%-59.31%-80.69%RBOTVicarious Surgical+21.05%+64.29%-11.54%-61.21%-91.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGCTKGlucoTrack 1.00SellN/AN/AITOCItonic 1.00SellN/AN/ANXGLNexGel 2.00Hold$2.00269.00% UpsideRBOTVicarious Surgical 1.67Reduce$7.00900.00% UpsideCurrent Analyst Ratings BreakdownLatest GCTK, ITOC, RBOT, and NXGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2026ITOCItonic Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026GCTKGlucoTrack Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/12/2026NXGLNexGel Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$6.00 ➝ $2.00(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGCTKGlucoTrackN/AN/AN/AN/A$2.80 per shareN/AITOCItonic$523.03K10.14N/AN/A$0.48 per share0.65NXGLNexGel$11.42M0.42N/AN/A$0.60 per share0.90RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGCTKGlucoTrack-$19.39M-$55.51N/AN/AN/AN/A-324.84%-178.16%N/AITOCItonic-$5.10MN/AN/AN/AN/AN/AN/AN/AN/ANXGLNexGel-$3M-$0.38N/AN/AN/A-26.27%-56.90%-28.42%N/ARBOTVicarious Surgical-$63.22M-$6.69N/AN/AN/AN/A-184.13%-112.50%7/30/2026 (Estimated)Latest GCTK, ITOC, RBOT, and NXGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026GCTKGlucoTrackN/A$2.65N/A$2.65N/AN/A5/14/2026Q1 2026NXGLNexGel-$0.07-$0.11-$0.04-$0.11$3.91 million$2.65 million3/31/2026Q4 2025NXGLNexGel-$0.09-$0.12-$0.03-$0.12$3.24 million$2.80 million3/30/2026Q4 2025ITOCItonicN/A-$0.0910N/A-$0.0910N/A$0.23 million3/9/2026Q4 2025RBOTVicarious Surgical-$1.37-$1.65-$0.28-$1.73N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGCTKGlucoTrackN/AN/AN/AN/AN/AITOCItonicN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGCTKGlucoTrack0.081.611.61ITOCItonicN/A8.838.72NXGLNexGel0.151.470.75RBOTVicarious SurgicalN/A4.754.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGCTKGlucoTrack10.92%ITOCItonicN/ANXGLNexGel2.21%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipGCTKGlucoTrack2.23%ITOCItonicN/ANXGLNexGel20.55%RBOTVicarious Surgical9.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGCTKGlucoTrack51.94 million1.90 millionNot OptionableITOCItonicN/A17.05 millionN/AN/ANXGLNexGel108.85 million7.03 millionNot OptionableRBOTVicarious Surgical2107.12 million5.89 millionNo DataGCTK, ITOC, RBOT, and NXGL HeadlinesRecent News About These CompaniesVicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical SettingMay 13 at 9:00 AM | globenewswire.comVicarious Surgical Reports First Quarter 2026 Financial ResultsApril 30, 2026 | globenewswire.comVicarious Surgical Shareholders Approve Reverse Stock Split AuthorizationApril 8, 2026 | tipranks.comVicarious Surgical, Inc. Class AApril 7, 2026 | edition.cnn.comVicarious Surgical completes testing milestone for surgical robotMarch 30, 2026 | massdevice.comVicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia RepairMarch 30, 2026 | globenewswire.comVicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq ListingMarch 25, 2026 | globenewswire.com‘Why do we exist?’: Inside Stephen From’s business strategy to get Vicarious Surgical to the finish lineMarch 20, 2026 | massdevice.comVicarious Fights to Stay Afloat & Other Medtech NewsMarch 19, 2026 | mddionline.comMThis surgical robotics company sees opportunity in hernia repairMarch 19, 2026 | medicaldesignandoutsourcing.comMVicarious Surgical pursues Nasdaq listing, cuts cash burn to $19MMarch 16, 2026 | massdevice.comVicarious Surgical applies for Nasdaq listingMarch 16, 2026 | medtechdive.comMVicarious Fights to Right the ShipMarch 16, 2026 | mddionline.comMVicarious Surgical Announces Strategic Plan to Pursue Nasdaq ListingMarch 16, 2026 | uk.finance.yahoo.comVicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 9, 2026 | businesswire.comVicarious Surgical Implements Executive Salary Reductions, Maintains IncentivesMarch 6, 2026 | tipranks.comVicarious Surgical receives NYSE delisting noticeMarch 4, 2026 | medtechdive.comMVicarious Surgical Confronted with NYSE Delisting Amid Ongoing ChallengesMarch 4, 2026 | mddionline.comMVicarious Surgical Receives Delisting Notice From NYSEMarch 4, 2026 | finance.yahoo.comVicarious Surgical faces NYSE delisting againMarch 4, 2026 | massdevice.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGCTK, ITOC, RBOT, and NXGL Company DescriptionsGlucoTrack NASDAQ:GCTK$0.67 -0.03 (-4.30%) Closing price 04:00 PM EasternExtended Trading$0.65 -0.02 (-2.52%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.Itonic NASDAQ:ITOC$0.31 +0.00 (+0.29%) Closing price 04:00 PM EasternExtended Trading$0.32 +0.00 (+1.29%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.NexGel NASDAQ:NXGL$0.54 +0.01 (+1.69%) Closing price 04:00 PM EasternExtended Trading$0.54 +0.00 (+0.37%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Vicarious Surgical NYSE:RBOT$0.70 +0.01 (+1.45%) As of 03:57 PM EasternVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
